Article on updates for PC Biochemical Recurrence.

[JPnSD]

Biochemical recurrence develops in almost one-third of men with PC who have had local therapies.

an article on best approaches and updates discusses intermittent ADT

ascopubs.org/doi/full/10.12...

[Tall_Allen]

I wonder where they came up with that incorrect statistic? Perhaps it's true if they don't restrict the time period to contemporary patients.

[Scout4answers in reply to Tall_Allen]

Are you suggesting it is higher that 1/3 or lower?

[Tall_Allen in reply to Scout4answers]

Much lower in contemporary patients.

[JRPnSD in reply to Tall_Allen]

Who collects those records? I had Biochemical Recurrence and I am sure it never got reported to any type of tracking agency.

[Tall_Allen in reply to JRPnSD]

Why are you sure? Most institutions collect those data. With patient electronic records, they are usually de-identified and reported in databases like NCDB, SEER and various registries. They are required to collect and report on clinical trials.

[JRPnSD in reply to Tall_Allen]

I received SOC, so no clinical trials were involved. My impression is that there was no tracking of the outcome given conversations with my URO.

[maley2711 in reply to Tall_Allen]

Could this explain the difference in numbers ......

urotoday.com/conference-hig...

" Following radical prostatectomy, approximately 27-53% of patients will experience BCR.1 However, only 30% of patients experiencing BCR after primary surgery will develop clinical recurrence, with only 16.4% dying from their disease. The main unfavorable prognostic factors are:

PSA doubling time (PSADT) of <=1 year

A pathological Gleason score 8-10.1

[Tall_Allen in reply to maley2711]

No, the problem is the dates.

[maley2711 in reply to Tall_Allen]

where can we look for the current more accurate numbers???